2023
DOI: 10.1016/j.conctc.2023.101172
|View full text |Cite|
|
Sign up to set email alerts
|

WITHDRAWN: Impact of Dapagliflozin on insulin secretory function and serum adipokine expression levels in patients with primary diagnosis of type 2 diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 24 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?